Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast.
about
Prognostic significance of tumour infiltrating B lymphocytes in breast ductal carcinoma in situ.Ductal Carcinoma In Situ Biology, Biomarkers, and Diagnosis.Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ.New Insights into Tumor-Infiltrating B Lymphocytes in Breast Cancer: Clinical Impacts and Regulatory Mechanisms.Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in IThe prognostic value of quantitative analysis of CCL5 and collagen IV in luminal B (HER2−) subtype breast cancer by quantum-dot-based molecular imaging.
P2860
Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Characterizing the immune micr ...... rcinoma in situ of the breast.
@en
Characterizing the immune micr ...... rcinoma in situ of the breast.
@nl
type
label
Characterizing the immune micr ...... rcinoma in situ of the breast.
@en
Characterizing the immune micr ...... rcinoma in situ of the breast.
@nl
prefLabel
Characterizing the immune micr ...... rcinoma in situ of the breast.
@en
Characterizing the immune micr ...... rcinoma in situ of the breast.
@nl
P2093
P2860
P1476
Characterizing the immune micr ...... rcinoma in situ of the breast.
@en
P2093
Booyeon Han
Ekene Ojukwu
Frederick Baehner
Gregor Krings
Jasmine Wong
Joe W Gray
Laura Esserman
Max Endicott
Michael J Campbell
P2860
P2888
P356
10.1007/S10549-016-4036-0
P407
P577
2016-10-26T00:00:00Z